Clinical trial

Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and…

NCT00384371 · United States Department of Defense, U.S. Fed · Terminated

Key facts

NCT number NCT00384371
Title Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain
Official title Pilot Study to Assess the Efficacy of Botulinum Toxin A (BOTOX®) Treatment of Paravertebral Muscles on Pain and Disability in Subjects Suffering From Sub-Acute Low Back Pain.
Lead sponsor United States Department of Defense, U.S. Fed
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Low Back Pain
Intervention type Drug
Interventions Botulinum Toxin A, Placebo
Enrollment 0
Start date Jun 1, 2008
Primary completion Sep 1, 2011
Completion Sep 1, 2011
First posted Oct 6, 2006
Last update posted Mar 5, 2009
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies